Savara (SVRA) Accumulated Expenses (2010 - 2026)
Savara's (SVRA) quarterly Accumulated Expenses came in at $11.0 million in Q1 2026, up 979.47% year-on-year from $1.0 million in Q1 2025, and down 24.56% on a QoQ basis from $14.6 million in Q4 2025.
Savara (SVRA) Accumulated Expenses (2010 - 2026) Analysis & Trends
Savara (SVRA) has 17 years of Accumulated Expenses data on file, last reported at $11.0 million in Q1 2026.
- On a quarterly basis, Accumulated Expenses rose 979.47% year-over-year to $11.0 million in Q1 2026; TTM through Mar 2026 was $11.0 million, a 979.47% increase from a year earlier, with the FY2025 full-year figure at $14.6 million, up 191.79% from the prior year.
- Accumulated Expenses for Q1 2026 stood at $11.0 million, down from $14.6 million in the prior quarter.
- Over the last five years, Accumulated Expenses for SVRA reached as high as $14.6 million in Q4 2025 and fell as low as $590000.0 in Q1 2022.
- Historically, Accumulated Expenses has averaged $4.3 million across 5 years, with a median of $2.9 million in 2022.
- Across the five-year window, Accumulated Expenses tumbled 71.41% in 2025 and surged 979.47% in 2026, its largest moves.
- Year by year, Accumulated Expenses stood at $2.4 million in 2022, then surged by 199.92% to $7.1 million in 2023, then retreated by 29.27% to $5.0 million in 2024, then surged by 191.79% to $14.6 million in 2025, then slipped by 24.56% to $11.0 million in 2026.
- Per Business Quant data, the three most recent Accumulated Expenses figures were $11.0 million in Q1 2026, $14.6 million in Q4 2025, and $3.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Savara | 1.24 Bn | 1.24 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.04 Mn |
| Dec 31, 2025 | 14.64 Mn |
| Sep 30, 2025 | 3.92 Mn |
| Jun 30, 2025 | 2.26 Mn |
| Mar 31, 2025 | 1.02 Mn |
| Dec 31, 2024 | 5.02 Mn |
| Sep 30, 2024 | 2.84 Mn |
| Jun 30, 2024 | 7.90 Mn |
| Mar 31, 2024 | 757,000.00 |
| Dec 31, 2023 | 7.09 Mn |
| Sep 30, 2023 | 2.18 Mn |
| Jun 30, 2023 | 3.38 Mn |
| Mar 31, 2023 | 603,000.00 |
| Dec 31, 2022 | 2.37 Mn |
| Sep 30, 2022 | 4.27 Mn |
| Jun 30, 2022 | 2.90 Mn |
| Mar 31, 2022 | 590,000.00 |
| Dec 31, 2021 | 4.88 Mn |
| Sep 30, 2021 | 5.22 Mn |
| Jun 30, 2021 | 1.53 Mn |